Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Clinical implication of low estrogen receptor (ER-low) expression in breast cancer.
Front Endocrinol (Lausanne). 2022 Nov 24;13:1015388. doi: 10.3389/fendo.2022.1015388. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 36506043
Free PMC article.
Review.
Gene expression signatures in early breast cancer: Better together with clinicopathological features.
Oliveira LJC, Amorim LC, Megid TBC, de Resende CAA, Mano MS.
Oliveira LJC, et al. Among authors: de resende caa.
Crit Rev Oncol Hematol. 2022 Jul;175:103708. doi: 10.1016/j.critrevonc.2022.103708. Epub 2022 May 14.
Crit Rev Oncol Hematol. 2022.
PMID: 35580764
Review.
Item in Clipboard
Implications of the PEARL trial from the low- to middle-income countries' perspectives.
Reinert T, Gonçalves AC, de Resende CAA, Barrios CH.
Reinert T, et al. Among authors: de resende caa.
Eur J Cancer. 2022 Sep;173:30-32. doi: 10.1016/j.ejca.2022.06.016. Epub 2022 Jul 13.
Eur J Cancer. 2022.
PMID: 35841844
No abstract available.
Item in Clipboard
Cite
Cite